Developing the analytics and analytical workflows supporting the analysis of the next generation of biotherapeutic and gene therapies
Presentations | 2020 | WatersInstrumentation
Consumables, Ion Mobility, HPLC, LC/TOF, LC/HRMS, LC/MS, LC/MS/MS, LC columns, LC/SQ
IndustriesPharma & Biopharma, Proteomics , Clinical Research
ManufacturerWaters
Key wordscapsid, aav, empty, development, gene, protein, capsids, therapy, proteins, sec, iex, full, rplc, monitoring, measure, characterization, vector, biopharmaceutical, bioaccord, arc, emerson, waldo, auc, viral, challenges, virus, peptide, flr, mass, native, acquity, purity, profile, identity, mapping, difference, analysis, formulated, ratio, bio, surfactant, ims, attribute, analytical, class, routine, separation, waters, batch, late
Similar PDF
Optimizing Adeno-Associated Virus (AAV) Capsid Protein Analysis Using UPLC and UPLC-MS
2020|Waters|Applications
[ APPLICATION NOTE ] Optimizing Adeno-Associated Virus (AAV) Capsid Protein Analysis Using UPLC and UPLC-MS Ximo Zhang, Stephan Koza, Ying Qing Yu, and Weibin Chen Waters Corporation, Milford, MA, USA APPLICATION BENEFITS ■ ■ INTRODUCTION An optimized LC-MS solution for…
Key words
capsid, capsidaav, aavadeno, adenouplc, uplcvirus, virusassociated, associatedproteins, proteinsoptimizing, optimizingraav, raavmass, massflr, flrtherapy, therapygene, geneacquity, acquityprotein
Advanced Therapeutic Medicinal Products: Adeno-associated Virus (AAV)
2021|Waters|Others
Advanced Therapeutic Medicinal Products: Adeno-associated Virus (AAV) The Promise of Viral Vector Gene Therapy using AAV 7000 Monogenic Diseases 20 of 22 4 Years Children with spinal muscular atrophy (SMA) given the ability to thrive with Zolgensma® (AAV) at 91%…
Key words
aav, aavbioprocess, bioprocessglossary, glossarycapsid, capsidmapping, mappingdiscovery, discoverygene, generegulatory, regulatorydevelopment, developmentspecifications, specificationstherapy, therapyvirus, virusadeno, adenoviral, viralexpression
Characterizing AAVs
2023|Waters|Guides
CONSUMABLES GUIDE BOOK Characterizing AAVs Chromatographic methods to measure heterogeneity and critical quality attributes CONSUMABLES GUIDE BOOK A Changing Industry Attribute Testing The advent of FDA approved gene therapies brings An AAV vectored therapy contains multiple types of biomolecules compromised…
Key words
aav, aavprotein, proteincapsid, capsidtransgene, transgenebook, bookaex, aexpak, pakencapsidation, encapsidationgenome, genomecolumn, columnpotency, potencyrplc, rplcdiameter, diameterempty, emptypeptide
Characterization of Viral Vector Particles Using the Agilent 6545XT AdvanceBio LC/Q-TOF
2020|Agilent Technologies|Applications
Application Note Pharma & Biopharma Characterization of Viral Vector Particles Using the Agilent 6545XT AdvanceBio LC/Q-TOF Authors Wendi A. Hale and Christopher M. Colangelo Agilent Technologies, Inc., Lexington, MA, USA Roy Hegedus and Norman Garceau Lake Pharma, Worcester, MA, USA…
Key words
capsid, capsidcounts, countsgene, genemass, massviral, viralcharge, chargepeptide, peptidedeconvoluted, deconvolutedadeno, adenoadvancebio, advancebiovector, vectorproteins, proteinscqas, cqasiterative, iterativetherapy